Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease

• Published in: Journal of translational medicine Vol. 16; no. 1; p. 159
• Main Authors: Hemstra, Line Ea, Schlosser, Anders, Lindholt, Jes Sanddal, Sorensen, Grith L
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.06.2018; BioMed Central; BMC
• Subjects: Angiogenesis; Arteries; Arteriosclerosis; Atherosclerosis; Biomarkers; Cardiovascular disease; Cardiovascular diseases; Causes of; Confidence intervals; Diabetes; Diagnosis; Extracellular matrix; Extremities; Family medical history; Hypertension; Ischemia; Liver cirrhosis; Lower-extremity ischemia; Matrix protein; Medical records; MFAP4; Mortality; Occlusion; Patients; Peripheral artery disease; Peripheral vascular diseases; Plastic surgery; Primary patency; Proteins; Reconstructive surgery; Regression analysis; Surgery; Survival analysis; Target recognition; Vascular diseases; Vascular surgery; Denmark; Peripheral artery disease; MFAP4; Mortality; Primary patency; Lower-extremity ischemia

Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular...